AJ91 — Doccheck AG Income Statement
0.000.00%
Last trade - 00:00
- €46.68m
- €32.60m
- €60.90m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28.3 | 32.4 | 63.1 | 85.9 | 60.9 |
Cost of Revenue | |||||
Gross Profit | 22.6 | 26 | 40.3 | 49.7 | 45.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24.6 | 27.8 | 49.3 | 69.3 | 50.5 |
Operating Profit | 3.73 | 4.58 | 13.8 | 16.6 | 10.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.38 | 4.62 | 13.9 | 17.3 | 9.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.22 | 3.1 | 9.61 | 11.8 | 6.27 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.27 | 3.14 | 9.2 | 11.4 | 6.29 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.27 | 3.14 | 9.2 | 11.4 | 6.29 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.476 | 0.729 | 1.88 | 2.3 | 1.28 |
Dividends per Share |